Rapport Therapeutics, Inc. (RAPP)
30.99
+1.14
(+3.82%)
USD |
NASDAQ |
Oct 09, 15:03
Rapport Therapeutics Price to Book Value : 3.514 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 3.385 |
| October 07, 2026 | 3.499 |
| October 06, 2026 | 3.532 |
| October 05, 2026 | 3.65 |
| October 02, 2026 | 3.648 |
| October 01, 2026 | 3.723 |
| September 30, 2026 | 3.810 |
| September 29, 2026 | 3.744 |
| September 28, 2026 | 3.792 |
| September 25, 2026 | 3.845 |
| September 24, 2026 | 3.836 |
| September 23, 2026 | 3.87 |
| September 22, 2026 | 4.702 |
| September 21, 2026 | 4.497 |
| September 18, 2026 | 4.587 |
| September 17, 2026 | 4.757 |
| September 16, 2026 | 4.693 |
| September 15, 2026 | 4.839 |
| September 14, 2026 | 4.989 |
| September 11, 2026 | 4.946 |
| September 10, 2026 | 4.928 |
| September 09, 2026 | 4.976 |
| September 08, 2026 | 5.226 |
| September 04, 2026 | 5.190 |
| September 03, 2026 | 5.403 |
| Date | Value |
|---|---|
| September 02, 2026 | 5.521 |
| September 01, 2026 | 5.506 |
| August 31, 2026 | 5.519 |
| August 28, 2026 | 5.53 |
| August 27, 2026 | 5.764 |
| August 26, 2026 | 5.953 |
| August 25, 2026 | 5.802 |
| August 24, 2026 | 5.594 |
| August 21, 2026 | 5.470 |
| August 20, 2026 | 5.426 |
| August 19, 2026 | 5.564 |
| August 18, 2026 | 5.557 |
| August 17, 2026 | 5.490 |
| August 14, 2026 | 5.377 |
| August 13, 2026 | 5.370 |
| August 12, 2026 | 5.412 |
| August 11, 2026 | 5.536 |
| August 10, 2026 | 5.327 |
| August 07, 2026 | 5.158 |
| August 06, 2026 | 5.256 |
| August 05, 2026 | 4.812 |
| August 04, 2026 | 4.785 |
| August 03, 2026 | 4.625 |
| July 31, 2026 | 4.647 |
| July 30, 2026 | 4.851 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.835 |
| Corcept Therapeutics, Inc. | 18.54 |
| Veru, Inc. | 1.484 |
| Johnson & Johnson | 7.373 |
| Eli Lilly & Co. | 32.63 |
Price to Book Value Related Metrics
| PS Ratio | 69.58 |
| PEG Ratio | -0.4330 |
| Price | 30.99 |
| Earnings Yield | -9.81% |
| Market Cap | 1.486B |
| PEGY Ratio | -0.4330 |